Published in J Clin Pathol on August 01, 1974
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev (1983) 5.73
Escherichia coli in extra-intestinal infections. J Hyg (Lond) (1985) 2.51
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun (1983) 2.26
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun (1982) 2.12
Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J Bacteriol (1987) 1.93
Plasmid carriage and the serum sensitivity of enterobacteria. Infect Immun (1978) 1.30
Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum. Infect Immun (1976) 1.27
Characterization of urinary Escherichia coli O75 strains. J Clin Microbiol (1997) 0.82
The real-time-based assessment of the microbial killing by the antimicrobial compounds of neutrophils. ScientificWorldJournal (2011) 0.76
A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest (1960) 4.69
The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology (1970) 3.53
Lysis of gram-negative bacteria by serum. J Gen Microbiol (1958) 2.42
Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms. Med Lab Technol (1972) 2.19
Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system. Am J Med Sci (1970) 2.05
THE EPIDEMIOLOGY OF NONENTERIC ESCHERICHIA COLI INFECTIONS. II. RELATIONSHIP OF PREVALENCE OF E. COLI IN URINARY INFECTIONS TO THE BACTERICIDAL EFFECT OF HUMAN SERUM. J Lab Clin Med (1964) 1.13
[Serum resistance and "nephropathogenicity" of antigenically defined strains of E. coli. I. Determination and standardization of serum sensitivity]. Z Med Mikrobiol Immunol (1970) 0.89
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev (1983) 5.73
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med (1996) 2.37
Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms. Med Lab Technol (1972) 2.19
Inflammation of the deep infrapatellar bursa of the knee. Arthritis Rheum (1989) 1.42
Serum bactericidal activity in patients with upper and lower urinary tract infections. Clin Sci (1972) 1.42
Enthesitis of the elbow in psoriatic arthritis. J Rheumatol (1997) 1.42
Neuraminidase associated with coliphage E that specifically depolymerizes the Escherichia coli K1 capsular polysaccharide. J Virol (1985) 1.38
Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol (1975) 1.37
Killing of an encapsulated strain of Escherichia coli by human serum. Infect Immun (1983) 1.35
Plasmid carriage and the serum sensitivity of enterobacteria. Infect Immun (1978) 1.30
A protein factor associated with serum resistance in Escherichia coli. J Med Microbiol (1977) 1.29
Determinants that increase the serum resistance of Escherichia coli. Infect Immun (1980) 1.28
Complete nucleotide sequence of the gene encoding bacteriophage E endosialidase: implications for K1E endosialidase structure and function. Biochem J (1995) 1.13
Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections. J Med Microbiol (1976) 1.13
Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep (2000) 1.12
Membrane changes induced by exposure of Escherichia coli to human serum. Infect Immun (1983) 1.12
Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol (2009) 1.08
Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J Clin Lab Immunol (1992) 1.07
Isolation and experimental infection of free-living amebae in freshwater fishes. J Parasitol (1977) 1.06
Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Mol Immunol (1984) 1.05
The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett Appl Microbiol (2007) 1.03
Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides. Biochemistry (1970) 1.01
Experimental Escherichia coli urinary infection in the rat. Kidney Int (1975) 1.01
Influence of pH on the kinetics of complex formation between aromatic sulfonamides and human carbonic anhydrase. Biochemistry (1970) 0.95
An antibactericidal factor in the serum of two patients with infections of the upper urinary tract. Clin Sci (1972) 0.93
Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum. J Med Microbiol (1981) 0.93
Determination of aflatoxins, ochratoxin a, and zearalenone in mixed feeds, with detection by thin layer chromatography or high performance liquid chromatography. J Assoc Off Anal Chem (1981) 0.92
Isolation of bacteriophages from the oral cavity. Lett Appl Microbiol (2004) 0.90
Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. J Appl Microbiol (2007) 0.90
Bacterial colonization and biofilm development on minimally processed vegetables. J Appl Microbiol (1998) 0.89
Uptake and metabolism of dl-norepinephrine by subcellular particles of rat heart. J Pharmacol Exp Ther (1968) 0.88
Septic arthritis due to Aerococcus viridans. J Rheumatol (1985) 0.87
Isolation and characterization of a serum antibactericidal factor. Clin Sci (1972) 0.86
Effect of lethal doses of complement on the functional integrity of target enterobacteria. Curr Top Microbiol Immunol (1985) 0.86
Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains. Antimicrob Agents Chemother (1981) 0.86
Identification of the B1 and B2 subunits of human placental laminin and rat parietal-yolk-sac laminin using antisera specific for murine laminin-beta-galactosidase fusion proteins. Biochem J (1990) 0.85
Kinetics of carbonic anhydrase-inhibitor complex formation. a comparison of anion- and sulfonamide-binding mechanisms. Biochemistry (1971) 0.85
Transfer of phospholipid and protein into the envelope of gram-negative bacteria by liposome fusion. Biochemistry (1989) 0.84
Investigation of the mechanism of ligand binding with cobalt(II) human carbonic anhydrase by 1 H and 19 F nuclear magnetic resonance spectroscopy. Biochemistry (1971) 0.84
The effect of immunosympathectomy on the retention and metabolism of noradrenaline. Acta Physiol Scand (1967) 0.83
Optimizing irradiation dose for sterility induction and quality of Bactrocera tryoni. J Econ Entomol (2009) 0.83
Osteonecrosis in sickle cell trait. J Rheumatol (1986) 0.82
Patient perception of medical care. Health Care Manage Rev (1981) 0.82
Subcellular distribution of norepinephrine in the normal and surgically denervated cat heart. Biochem Pharmacol (1966) 0.81
Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Photochem Photobiol (1996) 0.80
Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595. Biochem J (1989) 0.80
An unusual acidic polysaccharide produced by a rough strain of Escherichia coli. Biochem Biophys Res Commun (1974) 0.79
Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.79
Fish mortality in the Mississippi catfish farming industry in 1988: causes and treatments. J Wildl Dis (1991) 0.78
Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. Biochem Pharmacol (1992) 0.78
Broadcasts of wing-fanning vibrations recorded from calling male Ceratitis capitata (Diptera: Tephritidae) increase captures of females in traps. J Econ Entomol (2004) 0.78
Desiccation resistance of wild and mass-reared Bactrocera tryoni (Diptera: Tephritidae). Bull Entomol Res (2013) 0.78
A new metachromatic stain technique for paraffin-embedded neural tissue using thionin. J Microsc (1976) 0.76
The use of a real-time PCR primer/probe set to observe infectivity of Yersinia ruckeri in Chinook salmon, Oncorhynchus tshawytscha (Walbaum), and steelhead trout, Oncorhynchus mykiss (Walbaum). J Fish Dis (2011) 0.76
Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity. Biochemistry (1990) 0.76
Engineering proteins that bind to cell surface carbohydrates. Clin Chim Acta (1997) 0.76
Monoclonal antibodies specific for the C-terminus of the laminin B2 subunit. Evidence for glycosylation differences between murine and human laminin. Biochem J (1991) 0.75
Septic arthritis in Waldenstrom's macroglobulinemia. J Rheumatol (1994) 0.75
Investigation of the antibacterial activity of 3-O-octanoyl-(-)-epicatechin. J Appl Microbiol (2008) 0.75
The composition of acyl lipids and tocopherols in wheat germ oils from various sources. J Sci Food Agric (1980) 0.75
An alternative bacteriological medium for the isolation of Aeromonas spp. J Wildl Dis (1995) 0.75
The Memorial General Hospital Association experience. J Ambul Care Manage (1980) 0.75
Dissolution kinetics of certain crystalline forms of prednisolone. J Pharm Sci (1965) 0.75
A group therapy approach with hemodialysis patients and their families. J Am Assoc Nephrol Nurses Tech (1975) 0.75
Ankylosing spondylitis with unusual spinal deformity: a case report. J Rheumatol (1981) 0.75
Hypolipidaemic activity of a novel acyclic ansamycin derivative. Synthesis and pharmacokinetic and pharmacodynamic studies in rodents. Arzneimittelforschung (1992) 0.75
Development and use of a method of assessing patient perception of care. Hosp Health Serv Adm (1981) 0.75
Pain management in severely burned adults: a test of stress inoculation. J Behav Med (1981) 0.75
The effect of the uptake of particles on the chemotaxis of polymorphonuclear leucocytes in-vitro. J Pharm Pharmacol (1991) 0.75
Components derived from Pelargonium stimulate macrophage killing of Mycobacterium species. J Appl Microbiol (2009) 0.75
Phenotypic modification of the reactivity in human serum of Escherichia coli K1 isolates. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.75
In vitro interaction of zinc(II)-phthalocyanine-containing liposomes and plasma lipoproteins. J Photochem Photobiol B (1994) 0.75
Evaluating irradiation dose for sterility induction and quality control of mass-produced fruit fly Bactrocera tryoni (Diptera: Tephritidae). J Econ Entomol (2014) 0.75
Summary of bacterial isolates from farm-reared channel catfish (1979-1988). J Vet Diagn Invest (1992) 0.75
Hematologic reactions to chrysotherapy treated with iv N-acetylcysteine. J Rheumatol (1984) 0.75
A new effect of reserpine: accumulation of glycoprotein in the submaxillary gland. J Pharmacol Exp Ther (1967) 0.75
Monitoring quality of care. JAMA (1988) 0.75
An antibactericidal factor in the serum of some patients with infections of the upper urinary tract. Clin Sci (1971) 0.75
Interaction between zinc(II)-phthalocyanine-containing liposomes and human low density lipoprotein. J Photochem Photobiol B (1994) 0.75